{
  "prompt": {
    "guidelineId": "cg1127-neonatal-abstinence-scoring-pdf",
    "fieldsProcessed": [
      "humanFriendlyName",
      "organisation",
      "yearProduced",
      "summary"
    ],
    "enhancedFields": 4,
    "contentLength": 6543
  },
  "response": "{\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"Neonatal Abstinence Syndrome Assessment and Management\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"The text does not explicitly mention a specific publishing organization or institution such as NHS, NICE, WHO, RCOG, etc. Therefore, I cannot identify the organization name from the provided guideline text\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"The text provided does not contain a publication year. If you have another guideline text that includes the year, please share it, and I can extract the 4-digit year for you\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Neonatal Abstinence Syndrome (NAS) Guideline** **Scope**: Applies to pediatric, neonatal, and midwifery staff caring for newborns at risk of NAS due to maternal substance use. **Key Recommendations**: - **Assessment**: Monitor for withdrawal symptoms using scoring tools. - **Antenatal Care**: Provide education, social service referral, and neonatal unit visits if needed. Administer Hepatitis B vaccine if indicated. - **Perinatal Care**: Avoid pethidine/diamorphine in opiate-dependent mothers; do not give naloxone. - **Postnatal Care**: Keep mother and baby together. Observe for withdrawal; start pharmacological treatment if scores are high. - **Opiate withdrawal**: Start morphine (125 mcg/kg/day, 4x daily) and wean gradually. - **Non-opiate withdrawal**: Phenobarbitone for alcohol, chlorpromazine for benzodiazepines. - **Breastfeeding**: Encourage if safe based on maternal medication. - **Discharge Criteria**: Stable NAS scores, normal feeding/sleeping, no morphine dose changes for 36 hours. Ensure social support and follow-up. - **Education**: Provide parents with NAS information and monitoring rationale. **Monitoring**: Audit antenatal tasks, NAS scoring, and discharge planning\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "endpoint": "enhanceGuidelineMetadata",
  "timestamp": "2025-06-18T21-48-27",
  "textContent": "AI: DeepSeek (deepseek-chat)\n\nQ: {\n  \"guidelineId\": \"cg1127-neonatal-abstinence-scoring-pdf\",\n  \"fieldsProcessed\": [\n    \"humanFriendlyName\",\n    \"organisation\",\n    \"yearProduced\",\n    \"summary\"\n  ],\n  \"enhancedFields\": 4,\n  \"contentLength\": 6543\n}\n\nA: {\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"Neonatal Abstinence Syndrome Assessment and Management\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"The text does not explicitly mention a specific publishing organization or institution such as NHS, NICE, WHO, RCOG, etc. Therefore, I cannot identify the organization name from the provided guideline text\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"The text provided does not contain a publication year. If you have another guideline text that includes the year, please share it, and I can extract the 4-digit year for you\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Neonatal Abstinence Syndrome (NAS) Guideline** **Scope**: Applies to pediatric, neonatal, and midwifery staff caring for newborns at risk of NAS due to maternal substance use. **Key Recommendations**: - **Assessment**: Monitor for withdrawal symptoms using scoring tools. - **Antenatal Care**: Provide education, social service referral, and neonatal unit visits if needed. Administer Hepatitis B vaccine if indicated. - **Perinatal Care**: Avoid pethidine/diamorphine in opiate-dependent mothers; do not give naloxone. - **Postnatal Care**: Keep mother and baby together. Observe for withdrawal; start pharmacological treatment if scores are high. - **Opiate withdrawal**: Start morphine (125 mcg/kg/day, 4x daily) and wean gradually. - **Non-opiate withdrawal**: Phenobarbitone for alcohol, chlorpromazine for benzodiazepines. - **Breastfeeding**: Encourage if safe based on maternal medication. - **Discharge Criteria**: Stable NAS scores, normal feeding/sleeping, no morphine dose changes for 36 hours. Ensure social support and follow-up. - **Education**: Provide parents with NAS information and monitoring rationale. **Monitoring**: Audit antenatal tasks, NAS scoring, and discharge planning\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "ai_provider": "DeepSeek",
  "ai_model": "deepseek-chat",
  "token_usage": null
}